June 23, 2020 / 3:26 PM / 13 days ago

BRIEF-Cspc Pharmaceutical Says Bortezomib For Injection Obtains Drug Registration Approval By Npma Of PRC

June 23 (Reuters) - CSPC Pharmaceutical Group Ltd:

* CSPC PHARMACEUTICAL - BORTEZOMIB FOR INJECTION OBTAINS DRUG REGISTRATION APPROVAL BY NPMA OF PRC Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below